BLB(SZ:002286) Xin Lang Cai Jing·2025-09-04 05:33Company Overview - Baolingbao Bio-Technology Co., Ltd. is located in Dezhou, Shandong Province, and was established on October 16, 1997, with its listing date on August 28, 2009 [1] - The company's main business involves the research, production, and sales of functional sugars, with revenue composition as follows: starch sugars and others 29.89%, sugar-reducing sweeteners 26.55%, feed and by-products 22.40%, probiotics 13.48%, dietary fibers 7.39%, and others 0.29% [1] Stock Performance - As of September 4, Baolingbao's stock price increased by 2.06% to 10.90 CNY per share, with a total market capitalization of 4.143 billion CNY [1] - Year-to-date, the stock price has risen by 48.91%, but it has seen a decline of 5.22% over the last five trading days and a decrease of 5.63% over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" five times this year, with the most recent appearance on May 22, where it recorded a net buy of -50.8373 million CNY [1] Financial Performance - For the first half of 2025, Baolingbao achieved operating revenue of 1.399 billion CNY, representing a year-on-year growth of 18.02%, and a net profit attributable to shareholders of 92.672 million CNY, up 33.66% year-on-year [2] - The company has distributed a total of 309 million CNY in dividends since its A-share listing, with 9.507 million CNY distributed in the last three years [3] Shareholder Information - As of August 20, the number of shareholders for Baolingbao was 36,800, an increase of 0.89% from the previous period, with an average of 10,031 circulating shares per shareholder, a decrease of 0.88% [2]